WO2024121811 - COMPOSITION AND METHOD FOR PROLONG SURVIVAL OF TRANSPLANT AND RECIPIENT
National phase entry:
Publication Number
WO/2024/121811
Publication Date
13.06.2024
International Application No.
PCT/IB2023/062417
International Filing Date
08.12.2023
Title **
[English]
COMPOSITION AND METHOD FOR PROLONG SURVIVAL OF TRANSPLANT AND RECIPIENT
[French]
COMPOSITION ET MÉTHODE POUR PROLONGER LA SURVIE D'UN GREFFON ET D'UN RECEVEUR
Applicants **
NOVMETAPHARMA CO., LTD.
SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
SEOUL NATIONAL UNIVERSITY HOSPITAL
Inventors
YANG, Seung Hee
JUNG, Hoeyune
KIM, Jong Min
KIM, Yon Su
LEE, Heonjong
Priority Data
63/386,531
08.12.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
MOIP
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2350 | |
| EPO | Filing, Examination, Granting | 14550 | |
| Japan | Filing, Examination, Granting | 2336 | |
| South Korea | Filing, Examination, Granting | 1842 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
25,818
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
A treatment of rejection of a transplant by a recipient of the transplant is disclosed. Methods for prolonging transplant survival in a recipient of the transplant, prolonging survival of the recipient, delaying and/or suppressing delayed graft function in the recipient, and/or reducing the amount of an immunosuppressant administered for transplantation. The methods include providing the transplant with a CHP or a pharmaceutically acceptable salt thereof is disclosed. Also provided is a method for the production of a pharmaceutical composition for the treatment of a transplant allowing modulating transplant survival in a recipient of the transplant.[French]
Est divulgué ici un traitement anti-rejet d'un greffon par un receveur du greffon. Sont également divulguées des méthodes pour prolonger la survie d'un greffon chez un receveur du greffon, prolonger la survie du receveur, retarder et/ou supprimer la reprise retardée de fonction de greffon chez le receveur, et/ou réduire la quantité d'un immunosuppresseur administré pour une transplantation. Sont également divulguées des méthodes comprenant la fourniture du greffon avec un CHP ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également un procédé de production d'une composition pharmaceutique pour le traitement d'un greffon permettant de moduler la survie d'un greffon chez un receveur du greffon.